New Possibilities in Extemporaneous Preparation in Dermatology: Innovative Foam Base Espumil

July 2016 in “ Dermatologie pro praxi ”

Sylva Klovrzová, Soňa Brtnová, Lada Novotná

Espumil dexamethasone ichthamol miconazole chlorhexidine minoxidil Rogaine

Studysummary This article discusses the use of Espumil foam base in pharmacies for preparing dermatological medications and reports no new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The foam base Espumil expanded the possibilities for the extemporaneous preparation of medications in pharmacies, particularly in dermatology. It was used with active ingredients such as dexamethasone, ichthamol, miconazole, chlorhexidine, and minoxidil. These foam preparations were suitable for application on hair and hairy areas.

View this study on solen.cz →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Stability of Minoxidil in Espumil Foam Base

4 citations , June 2013 in “PubMed”

This study found that minoxidil in Espumil Foam Base remains stable for at least 90 days when stored at room temperature and protected from light.

research Role of Caffeine in the Management of Androgenetic Alopecia

11 citations , July 2012 in “International Journal of Trichology”

Caffeine may help hair growth in hereditary hair loss.

A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

research A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

81 citations , August 2011 in “Journal of The American Academy of Dermatology”

In this study, latanoprost significantly increased hair density in young men with mild androgenetic alopecia after 24 weeks, suggesting it may stimulate hair follicle activity and treat hair loss.